AbbVie ABBV
NYSE ABBV
$262.90 +2.97 (+1.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

AbbVie (ABBV) Other Non-Current Liabilities (2012 - 2026)

Updated

AbbVie (ABBV) recorded Other Non-Current Liabilities of $34.6 billion in Q2 2026, up 8.0% from $32.04 billion a year earlier and up 1.4% from the prior quarter.

Analysis

AbbVie (ABBV) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends

At the end of FY2025, AbbVie reported Other Non-Current Liabilities of $32.57 billion, up 8.1% from FY2024.

  • Annual Other Non-Current Liabilities has a five-year compound annual growth rate of 3.4% (FY2020 to FY2025).
  • Across earlier years, Other Non-Current Liabilities came in at $30.13 billion in FY2024 (-6.8%), $32.33 billion in FY2023 (+5.5%), $30.66 billion in FY2022 (+6.8%) and $28.7 billion in FY2021 (+4.0%).
  • The Q2 2026 figure is the highest quarterly Other Non-Current Liabilities in data going back to Q4 2012.
  • On a year-over-year basis, Other Non-Current Liabilities has increased for three consecutive quarters, with growth averaging 1.6% over the last eight quarters.
  • Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 24.4% in Q3 2021, against a decline of 6.8% in Q4 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $34.11 billion (Q1 2026), $32.57 billion (Q4 2025) and $31.66 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Vertex Pharmaceuticals 128.38 Bn 100.39 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 34.60 Bn
Mar 31, 2026 34.11 Bn
Dec 31, 2025 32.57 Bn
Sep 30, 2025 31.66 Bn
Jun 30, 2025 32.04 Bn
Mar 31, 2025 31.19 Bn
Dec 31, 2024 30.13 Bn
Sep 30, 2024 33.03 Bn
Jun 30, 2024 32.43 Bn
Mar 31, 2024 32.78 Bn
Dec 31, 2023 32.33 Bn
Sep 30, 2023 31.64 Bn
Jun 30, 2023 32.29 Bn
Mar 31, 2023 32.25 Bn
Dec 31, 2022 30.66 Bn
Sep 30, 2022 30.22 Bn
Jun 30, 2022 30.77 Bn
Mar 31, 2022 28.02 Bn
Dec 31, 2021 28.70 Bn
Sep 30, 2021 29.10 Bn
API Access

AbbVie Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ABBV&period=max&api_key=YOUR_API_KEY